Immuno-Colombia Introduction


The aim of the present course is to gather immunology PhD students and fellows in clinical specialties such as oncology, rheumatology, hematology and allergy among others, to discuss the immunological basis underlying the development of novel immunotherapeutic approaches. The specific aims are:

  • To review the immunological mechanisms and molecules targeted by the new immunotherapeutic strategies.
  • To analyze the seminal research publications related to discovery and translation into clinical useful products.
  • To understand the biotechnological processes required for the manufacturing of these immunotherapeutic agents.
  • To review the clinical trials that demonstrate the efficacy of such treatments and their limitations.
  • To understand the mechanisms of the immune-related adverse events occurring during treatment with these products.
  • To get acquainted with the immunological monitoring procedures and biomarkers used for the follow-up of patients treated with these products.
  • To review the possibilities for the development of new immunotherapeutic agents, as well as new possible applications.

All course´s activities will be on-line, 5 -16 April 2021 beginning at 8:00 (Colombia/US Eastern time), using the platform Zoom administered by the IMMUNOPAEDIA team. Faculty members teaching in the course have provided review papers to help build the online pre-course material.

FacultyTopicLearning Link
Carla RothlinAn introductory overview of immunotherapy Coming Soon
Betsy QuackenbushCheck-points blockade-based therapiesComing Soon
Dieter KabelitzPerspectives of gamma/delta T-cells for immunotherapy of Cancer Coming Soon
Sonia GuedanCART-T(NK), armored CARs TRUCK therapiesComing Soon
Gloria VásquezAnti-cytokines therapiesComing Soon
Soraya ZorroTILS-based therapiesComing Soon
Augusto OchoaMDSC Promote Tumor Growth and EscapeComing Soon
Olivera FinnCancer vaccinationComing Soon
Klaus PantelImmunological laboratory methods for patient’s follow-upComing Soon
International Union of Immunological SocietiesUniversity of South AfricaInstitute of Infectious Disease and Molecular MedicineScience Education PrizesElizabeth Glazer Pediatric Aids Foundation